[1]
Pisula, A., Sienicka, A., Dobrowolska-Redo, A., Kacperczyk-Bartnik, J. and Romejko-Wolniewicz, E. 2024. PARP inhibitors in ovarian cancer therapy. Prospects in Pharmaceutical Sciences. 22, 2 (Jun. 2024), 71–74. DOI:https://doi.org/10.56782/pps.185.